Results 121 to 130 of about 919 (150)
Some of the next articles are maybe not open access.
Update on recurrent vulvovaginal candidiasis
The Obstetrician & Gynaecologist, 2021Key Content Recurrent vulvovaginal candidiasis (RVVC) affects millions of women worldwide. Defined as four or more episodes per year of vulvovaginal candidiasis (VVC), it is a cause of significant morbidity, affecting quality of life, relationships and ability to work.
Amy Borland +4 more
openaire +1 more source
Pathogenesis of recurrent vulvovaginal candidiasis
Current Infectious Disease Reports, 2002Recurrent vulvovaginal candidiasis (RVVC) is by no means uncommon and is a source of considerable physical suffering, in addition to serving as a major therapeutic challenge. The syndrome is multifactorial in etiology, hence management strategies must recognize the complex etiologic pathways. Considerable progress has been made in identifying secondary
openaire +2 more sources
Efficacy and Safety of Oteseconazole in Recurrent Vulvovaginal Candidiasis
NEJM Evidence, 2022BACKGROUND: Management of recurrent vulvovaginal candidiasis (RVVC) is an unmet clinical challenge without approved treatment in the United States. Oteseconazole is a novel oral selective inhibitor of fungal CYP51, designed to treat RVVC without off-target toxicities.
Jack D, Sobel +6 more
openaire +2 more sources
Managing Recurrent Vulvovaginal Candidiasis
Obstetrical & Gynecological Survey, 1997To evaluate the efficacy of one-day, intermittent, monthly prophylaxis with 400 mg itraconazole in the management of recurrent vulvovaginal candidiasis.In a randomized trial, 57 patients and 57 controls with recurrent vulvovaginal candidiasis were assigned either to receive one-day monthly itraconazole prophylaxis for six months or no treatment ...
A, Spinillo +5 more
openaire +2 more sources
Pathogenesis and Treatment of Recurrent Vulvovaginal Candidiasis
Clinical Infectious Diseases, 1992In contrast to women who experience infrequent episodes of candidal vaginitis, patients with chronic and recurrent candidal vaginitis rarely have recognizable precipitating or causal factors. Analysis of vaginal yeast isolated from women with recurrent candidal vaginitis uncommonly reveals a higher percentage of non-albicans Candida species.
openaire +2 more sources
Zinc status in women with recurrent vulvovaginal candidiasis
American Journal of Obstetrics and Gynecology, 1986Zinc status has been shown to influence various cell-mediated immunologic mechanisms. These cell-mediated mechanisms are important in preventing mucocutaneous infections caused by Candida albicans. This study evaluated the relationship between zinc status and recurrent vaginal candidiasis by comparing plasma and erythrocyte zinc in 29 patients with ...
J, Edman, J D, Sobel, M L, Taylor
openaire +2 more sources
Recurrent vulvovaginal candidiasis.
Current women's health reports, 2002Widespread use of over-the-counter antifungal medications has contributed to a large increase in the number of women who experience more than three episodes of candida vulvovaginitis per year. These women are particularly prone to chronic vulvovaginal pain syndromes; as such, the value of aggressive therapy based on detailed diagnosis extends well ...
C, MacNeill, J C, Carey
openaire +1 more source
Recurrent vulvovaginal candidiasis.
Australian family physician, 2005Recurrent vulvovaginal candidiasis affects up to 5% of premenopausal women. It is often associated with significant morbidity and may be difficult to manage.This article discusses the pathogenesis investigations and management of recurrent vulvovaginal candidiasis.Recurrent vulvovaginal candidiasis may be misdiagnosed as presenting signs and symptoms ...
Belinda, Sheary, Linda, Dayan
openaire +1 more source
Management of Patients with Recurrent Vulvovaginal Candidiasis
Drugs, 2003Recurrent vulvovaginal candidiasis (RVVC) is by no means uncommon and is a source of considerable physical discomfort in addition to serving as a major therapeutic challenge. The syndrome is multifactorial in aetiology and hence management strategies must recognise the complex aetiological pathways.
openaire +2 more sources
Idiopathic Recurrent Vulvovaginal Candidiasis
The Journal for Nurse Practitioners, 2017• Recurrent vulvovaginal candidiasis can be treated with long-term fluconazole leading to complete resolution of the condition.
openaire +1 more source